General Information
Version
1.0 en
Revision date
2025-03-10
Product name
AR-R 17779 hydrochloride BioScience Grade
CAS No.
178419-42-6
REACH No
It
1.2.1 Relevant identified uses
Laboratory and analytical use
Emergency telephone
+49/(0)89 19240
Icons in SDS
Company Information
company name
Carl Roth GmbH + Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.2 Skin corrosion/irritation Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation Eye Dam. 1 H318 3.8R Specific target organ toxicity - single exposure (respir- STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16
Signal word
Danger Danger Not required
Hazard pictograms
GHS05, GHS07 H318 Causes serious eye damage. H335 May cause respiratory irritation. Labelling of packages where the contents do not exceed 10 ml
Hazard statements
H315 Causes skin irritation H318 Causes serious eye damage H335 May cause respiratory irritation Labelling of packages where the contents do not exceed 125 ml Not required
Precautionary statements
Not required
Results of PBT and vPvB assessment
According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation 1 Eye Dam. 1 H318 3.8R Specific target organ toxicity - single exposure (respir- 3 STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16
